283 related articles for article (PubMed ID: 11919736)
1. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
[TBL] [Abstract][Full Text] [Related]
2. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
3. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
[TBL] [Abstract][Full Text] [Related]
4. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
[TBL] [Abstract][Full Text] [Related]
6. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
7. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
[TBL] [Abstract][Full Text] [Related]
9. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
10. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
[No Abstract] [Full Text] [Related]
12. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
13. [Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation].
Vinogradova OA; Savchenko VG; Domracheva EV; Liubimova LS; Ol'shanskaia IuV; Diachenko LV; Parovichnikova EN; Mendeleeva LP; Zakharova AV
Ter Arkh; 2002; 74(7):38-44. PubMed ID: 12181833
[TBL] [Abstract][Full Text] [Related]
14. Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation.
Yong AS; Goldman JM
Bone Marrow Transplant; 1999 Apr; 23(8):827-8. PubMed ID: 10231146
[TBL] [Abstract][Full Text] [Related]
15. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.
Santucci MA; Trabetti E; Martinelli G; Buzzi M; Zaccaria A; Pileri S; Farabegoli P; Sabattini E; Tura S; Pignatti PF
Bone Marrow Transplant; 1992 Sep; 10(3):255-9. PubMed ID: 1422479
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.
Békássy AN; Hermans J; Gorin NC; Gratwohl A
Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701
[TBL] [Abstract][Full Text] [Related]
18. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
19. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT.
Ditschkowski M; Haferlach C; Schulte C; Trenschel R; Beelen DW
Bone Marrow Transplant; 2009 Aug; 44(4):265-6. PubMed ID: 19234516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
